en

PRODUCT DETAIL

Humira 20 mg injekčný roztok v naplnenej injekčnej striekačke

Code 6471C
MA number EU/1/03/256/022
Product Form: sol inj 2x0,2 ml/20 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: AbbVie Deutschland GmbH & Co. KG, Germany
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB04 Adalimumab
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 08.09.2003
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 25.01.2022
eu-flag.png sk-flag.png